P Marchetti
Overview
Explore the profile of P Marchetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
401
Citations
6676
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bonomo S, Marchetti P, Fasola S, Vesentini R, Marcon A, Ferrante G, et al.
Sci Rep
. 2023 Nov;
13(1):19047.
PMID: 37923929
An association between climatic conditions and asthma incidence has been widely assumed. However, it is unclear whether climatic variations have a fingerprint on asthma dynamics over long time intervals. The...
2.
Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol J, et al.
Clin J Am Soc Nephrol
. 2023 Mar;
3(1):7-9.
PMID: 37001057
No abstract available.
3.
Mercadante S, Caraceni A, Cuomo A, Mammucari M, Marchetti P, Mediati R, et al.
Eur Rev Med Pharmacol Sci
. 2023 Feb;
27(3):1134-1139.
PMID: 36808361
Objective: The aim of this study was to characterize breakthrough pain (BTcP) in patients with multiple myeloma (MM). Patients And Methods: This was a secondary analysis of a large multicenter...
4.
Di Pietro F, Verkhovskaia S, Mastroeni S, Carbone M, Abeni D, Di Rocco C, et al.
Clin Oncol (R Coll Radiol)
. 2021 Sep;
34(1):e18-e24.
PMID: 34563446
Aims: Cutaneous melanoma is one of the most immunogenic tumours. Immunotherapy with checkpoint inhibitors, such as anti-PD-1 antibodies, has significantly improved the prognosis in metastatic melanoma. However, only half of...
5.
Cazzaniga M, Vallini I, Montagna E, Amoroso D, Berardi R, Butera A, et al.
Breast Cancer Res Treat
. 2021 Sep;
190(3):415-424.
PMID: 34546500
Purpose: Triple-negative breast cancer (TNBC) represents a subtype of breast cancer which lacks the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2): TNBC...
6.
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
Krasniqi E, Sacconi A, Marinelli D, Pizzuti L, Mazzotta M, Sergi D, et al.
Biomark Res
. 2021 Jul;
9(1):57.
PMID: 34256855
Background: In Western countries, ovarian cancer (OC) still represents the leading cause of gynecological cancer-related deaths, despite the remarkable gains in therapeutical options. Novel biomarkers of early diagnosis, prognosis definition...
7.
Ceccarelli F, Botticelli A, Natalucci F, Olivieri G, Cirillo A, Alessandri C, et al.
Clin Transl Oncol
. 2021 Mar;
23(9):1961-1962.
PMID: 33728870
No abstract available.
8.
Cinti F, Mezza T, Severi I, Suleiman M, Cefalo C, Sorice G, et al.
Metabolism
. 2020 Nov;
114:154414.
PMID: 33129839
Aims/hypothesis: Type 2 diabetes (T2D) is characterized by a progressive loss of beta-cell function, and the "disappearance" of beta-cells in T2D may also be caused by the process of beta...
9.
Petrelli F, Rulli E, Labianca R, Lonardi S, Rosati G, Dotti K, et al.
Ann Oncol
. 2020 Oct;
32(1):66-76.
PMID: 33098997
Background: Oxaliplatin-based adjuvant chemotherapy is the standard treatment of high-risk colon cancer (CC). A shorter duration (3 months) can achieve a similar outcome [in terms of relapse-free survival (RFS)] to...
10.
Hoeffelin H, Marchetti P, Reginster P
Rev Med Liege
. 2020 Sep;
75(9):562-564.
PMID: 32909404
We report the case of a 28-year-old male admitted to the emergency department for generalized seizure. A brain computed tomography (CT) revealed a ruptured dermoid cyst of the supra-tentorial stage...